Stay updated with breaking news from Nasdaq Agle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Aeglea BioTherapeutics Stock Performance The stock has a market cap of $48.64 million, a PE ratio of -0.16 and a beta of 2.57. The company […]
StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Wells Fargo & Company increased their target price on shares of Aeglea BioTherapeutics from $8.75 to $12.50 and gave the stock an equal weight […]
Aeglea BioTherapeutics (NASDAQ:AGLE – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, November 1st. Aeglea BioTherapeutics (NASDAQ:AGLE – Get Free Report) last posted its earnings results on Friday, August 11th. The biotechnology company reported ($41.50) EPS for the quarter, missing analysts’ consensus estimates of ($4.50) by ($37.00). The company had […]
StockNews.com downgraded shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research note published on Tuesday morning. Several other research firms have also commented on AGLE. Stifel Nicolaus started coverage on shares of Aeglea BioTherapeutics in a report on Tuesday, July 25th. They issued a buy […]
StockNews.com cut shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research report released on Tuesday morning. Several other research analysts have also weighed in on the stock. Stifel Nicolaus assumed coverage on shares of Aeglea BioTherapeutics in a report on Tuesday, July 25th. They set […]